Critical Appraisal of C-Reactive Protein Throughout the Spectrum of Cardiovascular Disease

References

• AlbertMAGlynnRJRidkerPMAlcohol consumption and plasma concentration of C-reactive proteinCirculation2003107443712551869
   PubMed Web of Science ®Google Scholar
• Alonso-MartinezJLLlorente-DiezBEchegaray-AgaraMC-reactive protein as a predictor of improvement and readmission in heart failureEur J Heart Fail20024331612034159
   PubMed Web of Science ®Google Scholar
• AndersonJLAllen MaycockCALappeDLFrequency of elevation of C-reactive protein in atrial fibrillationAm J Cardiol2004941255915541240
   PubMed Web of Science ®Google Scholar
• AngioiMAbdelmouttalebIRodriguezRMIncreased C-reactive protein levels in patients with in-stentAm J Cardiol20018711899311356396
   PubMed Web of Science ®Google Scholar
• AronsonDSellaRSheikh-AhmadMThe association between cardiorespiratory fitness and C-reactive protein in subjects with the metabolic syndromeJ Am Coll Cardiol2004442003715542283
   PubMed Web of Science ®Google Scholar
• AvilesRJMartinDOApperson-HansenCInflammation as a risk factor for atrial fibrillationCirculation200310830061014623805
   PubMed Web of Science ®Google Scholar
• AzarRRKlaymeSGermanosMEffects of aspirin (325 mg/day) on serum high-sensitivity C-reactive protein, cytokines, and adhesion molecules in healthy volunteersAm J Cardiol200392236912860235
   PubMed Web of Science ®Google Scholar
• BhattDLTopolEJNeed to test the arterial inflammation hypothesisCirculation20021061364012093783
   PubMed Web of Science ®Google Scholar
• BazzinoOFerreirosERPizarroRC-reactive protein and the stress tests for the risk stratification of patients recovering from unstable angina pectorisAm J Cardiol2001871235911377346
   PubMed Web of Science ®Google Scholar
• BellamyMFPellikkaPAKlarichKWAssociation of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the communityJ Am Coll Cardiol20024017233012446053
   PubMed Web of Science ®Google Scholar
• BiasucciLMLiuzzoGGrilloRLElevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instabilityCirculation1999998556010027805
   PubMed Web of Science ®Google Scholar
• BlakeGJRidkerPMNovel clinical markers of vascular wall inflammationCirc Res2001897637111679405
   PubMed Web of Science ®Google Scholar
• BogatyPBrophyJMNoelMImpact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled studyCirculation2004110934915302800
   PubMed Web of Science ®Google Scholar
• BraunwaldEDomanskiMJFowlerSEAngiotensin-converting-enzyme inhibition in stable coronary artery diseaseN Engl J Med200435120586815531767
   PubMed Web of Science ®Google Scholar
• BresalierRSSandlerRSQuanHCardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trialN Engl J Med2005352109210215713943
   PubMed Web of Science ®Google Scholar
• CampbellDJWoodwardMChalmersJPPrediction of heart failure by amino terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular diseaseHypertension200545697415569851
   PubMed Web of Science ®Google Scholar
• CermakJKeyNSBachRRC-reactive protein induces human peripheral blood monocytes to synthesize tissue factorBlood199382513208329706
   PubMed Web of Science ®Google Scholar
• ChanAWBahttDLChewDPRelation of inflammation and benefit of statins after percutaneous interventionsCirculation20031071750612665489
   PubMed Web of Science ®Google Scholar
• ChewDPBhattDLRobbinsMAIncremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary interventionCirculation2001a104992711524391
   PubMed Web of Science ®Google Scholar
• ChewDPBhattDLRobbinsMAEffect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive proteinAm J Cardiol2001b886727411564394
   PubMed Web of Science ®Google Scholar
• ChrysohoouCPanagiotakosDBPitsavosCAdherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA StudyJ Am Coll Cardiol200444152815234425
   PubMed Web of Science ®Google Scholar
• ChungMKMartinDOSprecherDC-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillationCirculation200110428869111739301
   PubMed Web of Science ®Google Scholar
• ChurchTSBarlowCEEarnestCPKampertJBAssociations between cardiorespiratory fitness and C-reactive protein in menArterioscler Thromb Vasc Biol20022218697612426218
   PubMed Web of Science ®Google Scholar
• CipolloneFMariniMFaziaMElevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplastyArterioscler Thromb Vasc Biol2001213273411231910
   PubMed Web of Science ®Google Scholar
• ConwayDSBugginsPHughesEPredictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillationAm J Cardiol2004a945081015325942
   PubMed Web of Science ®Google Scholar
• ConwayDSBugginsPHughesERelationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillationJ Am Coll Cardiol2004b4320758215172416
   PubMed Web of Science ®Google Scholar
• ConwayDSBugginsPHughesERelation of interleukin-6, C-reactive protein, and the prothrombotic state to transesophageal echocardiographic findings in atrial fibrillationAm J Cardiol2004c9313687315165916
   PubMed Web of Science ®Google Scholar
• CowellSJNewbyDEPrescottRJA randomized trial of intensive lipid-lowering therapy in calcific aortic stenosisN Engl J Med200535223899715944423
   PubMed Web of Science ®Google Scholar
• CushmanMLegaultCBarrett-ConnorEEffect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) StudyCirculation19991007172210449693
   PubMed Web of Science ®Google Scholar
• DaneshJWhincupPWalkerMLow grade inflammation and coronary heart disease: prospective study and updated meta-analysesBr Med J200032119920410903648
   PubMed Web of Science ®Google Scholar
• DaneshJWheelerJGHirschfieldGMC-reactive protein and other circulating markers of inflammation in the prediction of coronary heart diseaseN Engl J Med200435013879715070788
   PubMed Web of Science ®Google Scholar
• DesprésJPGolayASjostromLEffects of Rimonabant on metabolic risk factors in overweight patients with dyslipidemiaN Engl J Med200535321213416291982
   PubMed Web of Science ®Google Scholar
• DevarajSXuDYJialalIC-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosisCirculation200310739840412551862
   PubMed Web of Science ®Google Scholar
• Di NapoliMPapaFAngiotensin-converting enzyme inhibitor use is associated with reduced plasma concentration of C-reactive protein in patients with first-ever ischemic strokeStroke2003342922914605324
   PubMed Web of Science ®Google Scholar
• EisenbergMSChenHJWarshofskyMKElevated levels of plasma C-reactive protein are associated with decreased graft survival in cardiac transplant recipientsCirculation20001022100411044427
   PubMed Web of Science ®Google Scholar
• ElsterSKBraunwaldEWoodHFA study of C-reactive protein in the serum of patients with congestive heart failureAm Heart J1956515334113302128
   PubMed Web of Science ®Google Scholar
• EspositoKPontilloADi PaloCEffect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trialJAMA2003289179980412684358
   PubMed Web of Science ®Google Scholar
• FeldmanMJialalIDevarajSEffects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assayJ Am Coll Cardiol20013720364111419884
   PubMed Web of Science ®Google Scholar
• FengDTracyRPLipinskaIEffect of short-term aspirin use on C-reactive proteinJ Thromb Thrombolysis20001374110590187
   PubMedGoogle Scholar
• FerrariRBachettiTConfortiniRTumor necrosis factor soluble receptors in patients with various degrees of congestive heart failureCirculation1995921479867664430
   PubMed Web of Science ®Google Scholar
• FerreirosERBoissonnetCPPizarroRIndependent prognostic value of elevated C-reactive protein in unstable anginaCirculation199910019586310556221
   PubMed Web of Science ®Google Scholar
• FliserDBuchholzKHallerHAntiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammationCirculation20041101103715313950
   PubMed Web of Science ®Google Scholar
• FoxKMEURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)Lancet2003362782813678872
   PubMed Web of Science ®Google Scholar
• GalanteAPietroiustiAVelliniMC-reactive protein is increased in patients with degenerative aortic valvular stenosisJ Am Coll Cardiol20013810788211583885
   PubMed Web of Science ®Google Scholar
• GaspardoneACreaFVersaciFPredictive value of C-reactive protein after successful coronary-artery stenting in patients with stable anginaAm J Cardiol199882515189723643
   PubMed Web of Science ®Google Scholar
• GerberILStewartRAHammettCJEffect of aortic valve replacement on C-reactive protein in nonrheumatic aortic stenosisAm J Cardiol20039211293214583374
   PubMed Web of Science ®Google Scholar
• Gottsauner-WolfMZasmetaGHornykewyczSPlasma levels of C-reactive protein after coronary stent implantationEur Heart J2000211152810924298
   PubMed Web of Science ®Google Scholar
• HarrisTBFerrucciLTracyRPAssociations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderlyAm J Med19991065061210335721
   PubMed Web of Science ®Google Scholar
• HaverkateFThompsonSGPykeSDProduction of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study GroupLancet199734946269040576
   PubMed Web of Science ®Google Scholar
• HeeschenCHammCWBruemmerJPredictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trialJ Am Coll Cardiol20003515354210807457
   PubMed Web of Science ®Google Scholar
• HeeschenCDimmelerSHammCWSerum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromesCirculation200310721091412668510
   PubMed Web of Science ®Google Scholar
• HeilbronnLKCliftonPMC-reactive protein and coronary artery disease: influence of obesity, caloric restriction and weight lossJ Nutr Biochem2002133162112088796
   PubMed Web of Science ®Google Scholar
• HerringtonDMHowardTDBrosnihanKBCommon estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive proteinCirculation200210518798211997270
   PubMed Web of Science ®Google Scholar
• HerringtonDMBrosnihanKBPusserBEDifferential effects of E and droloxifene on C-reactive protein and other markers of inflammation in healthy postmenopausal womenJ Clin Endocrinol Metab20018642162211549652
   PubMed Web of Science ®Google Scholar
• HognestadAEndresenKWergelandRPlasma C-reactive protein as a marker of cardiac allograft vasculopathy in heart transplant recipientsJ Am Coll Cardiol2003424778212906976
   PubMed Web of Science ®Google Scholar
• HwangSJBallantyneCMSharrettARCirculating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) studyCirculation1997964219259416885
   PubMed Web of Science ®Google Scholar
• IkonomidisIAndreottiFEconomouEIncreased proinflammatory cytokines in patients with chronic stableCirculation1999100793810458713
   PubMed Web of Science ®Google Scholar
• ImhofAFrohlichMLoewelHDistributions of C-reactive protein measured by high-sensitivity assays in apparently healthy men and women from different populations in EuropeClin Chem2003496697212651827
   PubMed Web of Science ®Google Scholar
• JamesSKArmstrongPBarnathanETroponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudyJ Am Coll Cardiol2003419162412651034
   PubMed Web of Science ®Google Scholar
• JialalISteinDBalisDEffect of hydroxymethyl glutaryl coenzyme a reductase inhibitorCirculation200110319333511306519
   PubMed Web of Science ®Google Scholar
• KanekoKKandaTHasegawaAC-reactive protein as a prognostic marker in lymphocytic myocarditisJpn Heart J20004141710807528
   PubMedGoogle Scholar
• KapyahoKWelinMGTannerPRapid determination of C-reactive protein by enzyme immunoassay using two monoclonal antibodiesScand J Clin Lab Invest198949389932662385
   PubMed Web of Science ®Google Scholar
• KennonSPriceCPMillsPGThe effect of aspirin on C-reactive protein as a marker of risk in unstable anginaJ Am Coll Cardiol20013712667011300433
   PubMed Web of Science ®Google Scholar
• KervinenHManttariMKaartinenMPrognostic usefulness of plasma monocyte/macrophage and T-lymphocyte activation markers in patients with acute coronary syndromesAm J Cardiol200494993615476610
   PubMed Web of Science ®Google Scholar
• KheraAMcGuireDKMurphySARace and Gender Differences in C-Reactive Protein LevelsJ Am Coll Cardiol200546464916053959
   PubMed Web of Science ®Google Scholar
• KheraAde LemosJAPeshockRMRelationship between C-reactive protein and subclinical atherosclerosis. The Dallas Heart StudyCirculation2006113384316380546
   PubMed Web of Science ®Google Scholar
• KhreissTJozsefLPotempaLConformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cellsCirculation200410920162215051635
   PubMed Web of Science ®Google Scholar
• KinlaySSchwartzGGOlssonAGHigh dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL studyCirculation20031081560612975259
   PubMed Web of Science ®Google Scholar
• KnoopsKTde GrootLCKromhoutDMediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE projectJAMA20042921433915383513
   PubMed Web of Science ®Google Scholar
• KobashigawaJAKatznelsonSLaksHEffect of pravastatin on outcomes after cardiac transplantationN Engl J Med199533362177637722
   PubMed Web of Science ®Google Scholar
• KoenigWSundMFrohlichMC-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992Circulation199999237429892589
   PubMed Web of Science ®Google Scholar
• KoenigWLowelHBaumertJC-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern GermanyCirculation200410913495315023871
   PubMed Web of Science ®Google Scholar
• KullerLHTracyRPShatenJRelation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention TrialAm J Epidemiol1996144537478797513
   PubMed Web of Science ®Google Scholar
• KushnerIC-reactive protein and the acute-phase responseHosp Pract 30199025218
   Web of Science ®Google Scholar
• L'AllierPLTardifJCGrégoireJSustained elevation of serum CD40 ligand levels one month after coronary angioplasty predicts angiographic restenosisCan J Cardiol20052149550015917878
   PubMed Web of Science ®Google Scholar
• L'AllierPLInflammation in atherothrombotic diseaseJ Inv Cardiol200441S44S
   PubMedGoogle Scholar
• LedueTBWeinerDLSipeJDAnalytical evaluation of particle-enhanced immunonephelometric assaysAnn Clin Biochem199835745539838988
   PubMed Web of Science ®Google Scholar
• LindahlBTossHSiegbahnAMarkers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery DiseaseN Engl J Med200034311394711036119
   PubMed Web of Science ®Google Scholar
• LiuzzoGBiasucciLMGallimoreJRThe prognostic value of C-reactive protein and serum amyloid a protein in severe unstable anginaN Engl J Med1994331417247880233
   PubMed Web of Science ®Google Scholar
• LiuzzoGBiasucciLMRebuzziAGPlasma protein acute-phase response in unstable angina is not inducedCirculation1996942373808921776
   PubMed Web of Science ®Google Scholar
• MacGowanGAMannDLKormosRLCirculating interleukin-6 in severe heart failureAm J Cardiol1997791128319114781
   PubMed Web of Science ®Google Scholar
• MattuschFDufauxBHeineOReduction of the plasma concentration of C-reactive protein following nine months of endurance trainingInt J Sports Med20002121410683094
   PubMed Web of Science ®Google Scholar
• McAdamBFCatella-LawsonFMardiniIASystemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2Proc Natl Acad Sci U S A19999627279874808
   PubMed Web of Science ®Google Scholar
• Meier-EwertHKRidkerPMRifaiNAbsence of diurnal variation of C-reactive protein concentrations in healthy human subjectsClin Chem2001474263011238292
   PubMed Web of Science ®Google Scholar
• MendallMAStrachanDPButlandBKC-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in menEur Heart J20002115849010988010
   PubMed Web of Science ®Google Scholar
• MilazzoDBiasucciLMLucianiNElevated levels of C-reactive protein before coronary artery bypass grafting predict recurrence of ischemic eventsAm J Cardiol1999844596110468087
   PubMed Web of Science ®Google Scholar
• MiyauchiTMasakiTPathophysiology of endothelin in the cardiovascular systemAnnu Rev Physiol19996139141510099694
   PubMed Web of Science ®Google Scholar
• MonakierDMatesMKlutsteinMWRofecoxib, a COX-2 inhibitor, lowers C-reactive protein and interleukin-6 levels in patients with acute coronary syndromesChest200412516101515136366
   PubMed Web of Science ®Google Scholar
• MontalescotGPhilippeFAnkriAEarly increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE TrialCirculation19989829499711933
   PubMed Web of Science ®Google Scholar
• MorrowDARifaiNAntmanEMC-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in myocardial infarctionJ Am Coll Cardiol199831146059626820
   PubMed Web of Science ®Google Scholar
• MukherjeeDNissenSETopolEJRisk of cardiovascular events associated with selective COX-2 inhibitorsJAMA2001286954911509060
   PubMed Web of Science ®Google Scholar
• MullerCBuetterHJHoggsonJMInflammation and long-term mortality after non ST elevation acute coronary syndromes treated with a very early invasive strategy in 1042 consecutive patientsCirculation200210514121511914246
   PubMed Web of Science ®Google Scholar
• NiculescuFRusHComplement activation and atherosclerosisMol Immunol1999369495510698349
   PubMed Web of Science ®Google Scholar
• NissenSETuzcuMShoenhagenPStatin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery DiseaseN Engl J Med2005352293815635110
   PubMed Web of Science ®Google Scholar
• NovaroGMTiongIYPearceGLEffect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosisCirculation20011042205911684632
   PubMed Web of Science ®Google Scholar
• NussmeierNAWheltonAABrownMTComplications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgeryN Engl J Med200535210819115713945
   PubMed Web of Science ®Google Scholar
• OltronaLArdissinoDMerliniPAC-reactive protein elevation and early outcome in patients with unstable angina pectorisAm J Cardiol199780100269352968
   PubMed Web of Science ®Google Scholar
• PasceriVWillersonJTYehETDirect proinflammatory effect of C-reactive protein on human endothelial cellsCirculation20001022165811056086
   PubMed Web of Science ®Google Scholar
• PasceriVChengJSWillersonJTModulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugsCirculation20011032531411382718
   PubMed Web of Science ®Google Scholar
• PearsonTAMensahGAAlexanderRWCenters for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart AssociationCirculation200310749951112551878
   PubMed Web of Science ®Google Scholar
• PyeMRaeAPCobbeSMStudy of serum C-reactive protein concentration in cardiac failureBr Heart J199063228302337494
   PubMedGoogle Scholar
• RebuzziAGQuarantaGLiuzzoGIncremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectorisAm J Cardiol199882715199761079
   PubMed Web of Science ®Google Scholar
• RidkerPMHigh-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular diseaseCirculation2001a10318131811282915
   PubMed Web of Science ®Google Scholar
• RidkerPMRole of inflammatory biomarkers in prediction of coronary heart diseaseLancet2001b358946811583743
   PubMed Web of Science ®Google Scholar
• RidkerPMClinical application of C-reactive protein for cardiovascular disease detection and preventionCirculation2003b107363912551853
   PubMed Web of Science ®Google Scholar
• RidkerPMBuringJERifaiNSoluble P-selectin and the risk of future cardiovascular eventsCirculation2001103491511157711
   PubMed Web of Science ®Google Scholar
• RidkerPMBuringJEShihJProspective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy womenCirculation19989873139727541
   PubMed Web of Science ®Google Scholar
• RidkerPMCannonCPMorrowDC-reactive protein levels and outcomes after statin therapyN Eng J Med2005352208
   PubMed Web of Science ®Google Scholar
• RidkerPMRifaiNRoseLComparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular eventsN Engl J Med200234715576512432042
   PubMed Web of Science ®Google Scholar
• RidkerPMCushmanMStampferMJInflammation, aspirin, and the risk of cardiovascular disease in apparently healthy menN Engl J Med199733697399077376
   PubMed Web of Science ®Google Scholar
• RidkerPMCushmanMStampferMJPlasma concentration of C-reactive protein and risk of developing peripheral vascular diseaseCirculation19989742589490235
   PubMed Web of Science ®Google Scholar
• RidkerPMGlynnRJHennekensCHC-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarctionCirculation1998972007119610529
   PubMed Web of Science ®Google Scholar
• RidkerPMHennekensCHBuringJEC-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in womenN Engl J Med20003428364310733371
   PubMed Web of Science ®Google Scholar
• RidkerPMHennekensCHRifaiNHormone replacement therapy and increased plasma concentration of C-reactive proteinCirculation19991007131610449692
   PubMed Web of Science ®Google Scholar
• RidkerPMHennekensCHRoitman-JohnsonBPlasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy menLancet199835188929439492
   PubMed Web of Science ®Google Scholar
• RidkerPMJUPITER Study GroupRosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trialCirculation2003a1082292714609996
   PubMed Web of Science ®Google Scholar
• RidkerPMRifaiNClearfieldMAir Force/Texas Coronary Atherosclerosis Prevention Study Investigators. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary eventsN Engl J Med200134419596511430324
   PubMed Web of Science ®Google Scholar
• RidkerPMRifaiNPfefferMALong-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) InvestigatorsCirculation1999100230510411845
   PubMed Web of Science ®Google Scholar
• RidkerPMRifaiNStampferMJPlasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy menCirculation200010117677210769275
   PubMed Web of Science ®Google Scholar
• RifaiNRidkerPMPopulation distributions of C-reactive protein in apparently healthy men and women in the United States implication for clinical interpretationClin Chem200349666912651826
   PubMed Web of Science ®Google Scholar
• RobertsWLSedrickRMoultonLEvaluation of four automated high-sensitivity C-reactive proteinClin Chem200046461810759469
   PubMed Web of Science ®Google Scholar
• RoivainenMViik-KajanderMPalosuoTInfections, inflammation, and the risk of coronary heart diseaseCirculation2000101252710645920
   PubMed Web of Science ®Google Scholar
• SabatineMSMorrowDAde LemosJAMulti-marker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptideCirculation20021051760311956114
   PubMed Web of Science ®Google Scholar
• SamsonovMLopatinJTilzGPThe activated immune system and the renin-angiotensin-aldosterone system in congestive heart failureJ Intern Med19982439389566636
   PubMed Web of Science ®Google Scholar
• SolomonSDMcMurrayJJPfefferMACardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma preventionN Engl J Med200535210718015713944
   PubMed Web of Science ®Google Scholar
• TardifJCGrégoireJLavoieMAVascular protectants for the treatment of atherosclerosisExpert Rev Cardiovasc Ther200313859215030266
   PubMedGoogle Scholar
• ThambidoraiSKParakhKMartinDORelation of C-reactive protein correlates with risk of thromboembolism in patients with atrial fibrillationAm J Cardiol200494805715374796
   PubMed Web of Science ®Google Scholar
• TomodaHAokiNInstability of coronary lesions in unstable angina assessed byAm J Cardiol200187221311152846
   PubMed Web of Science ®Google Scholar
• TossHLindahlBSiegbahnAPrognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery DiseaseCirculation1997964204109416883
   PubMed Web of Science ®Google Scholar
• TracyRPLemaitreRNPsatyBMRelationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion ProjectArterioscler Thromb Vasc Biol199717112179194763
   PubMed Web of Science ®Google Scholar
• TrichopoulouACostacouTBamiaCAdherence to a Mediterranean diet and survival in a Greek populationN Engl J Med2003348259960812826634
   PubMed Web of Science ®Google Scholar
• VerheggenPWde MaatMPCatsVMInflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell functionEur Heart J1999205677410337541
   PubMed Web of Science ®Google Scholar
• VermaSLiSHBadiwalaMVEndothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive proteinCirculation20021051890611997273
   PubMed Web of Science ®Google Scholar
• VermaSWangCHLiSHA self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesisCirculation20021069131912186793
   PubMed Web of Science ®Google Scholar
• VermaSBadiwalaMVWeiselRDC-reactive protein activates the nuclear factor-kappaB signal transduction pathway in saphenous vein endothelial cells: implications for atherosclerosis and restenosisJ Thorac Cardiovasc Surg200312618869114688701
   PubMed Web of Science ®Google Scholar
• VermaSKuliszewskiMALiSHC-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular diseaseCirculation200410920586715078802
   PubMed Web of Science ®Google Scholar
• VermaSSzmitkoPEYehETC-reactive protein: structure affects functionCirculation200410919141715117860
   PubMed Web of Science ®Google Scholar
• VisserMBouterLMMcQuillanGMElevated C-reactive protein levels in overweight and obese adultsJAMA19992822131510591334
   PubMed Web of Science ®Google Scholar
• VivekananthanDPBhattDLChewDPEffect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary interventionAm J Cardiol2004943586015276105
   PubMed Web of Science ®Google Scholar
• VolpatoSPahorMFerrucciLRelationship of alcohol intake with inflammatory markers and plasminogen activator inhibitor-1 in well-functioning older adults: the Health, Aging, and Body Composition studyCirculation20041096071214769682
   PubMed Web of Science ®Google Scholar
• WannametheeSGLoweGDWhincupPHPhysical activity and hemostatic and inflammatory variables in elderly menCirculation200210517859011956120
   PubMed Web of Science ®Google Scholar
• WolbinkGJBrouwerMCBuysmannSCRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexesJ Immunol199615747398683153
   PubMed Web of Science ®Google Scholar
• YildirirAAybarFTokgozogluLEffects of hormone replacement therapy on plasma homocysteine and C-reactive protein levelsGynecol Obstet Invest20025354811803230
   PubMed Web of Science ®Google Scholar
• YudkinJSStehouwerCDEmeisJJC-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?Arterioscler Thromb Vasc Biol199919972810195925
   PubMed Web of Science ®Google Scholar
• YudkinJSKumariMHumphriesSEInflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?Atherosclerosis20001482091410657556
   PubMed Web of Science ®Google Scholar
• YusufSSleightPPogueJEffects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study InvestigatorsN Engl J Med20003421455310639539
   PubMed Web of Science ®Google Scholar
• ZwakaTPHombachVTorzewskiJC-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosisCirculation20011031194711238260
   PubMed Web of Science ®Google Scholar